ECG Criteria for Left Ventricular Hypertrophy in Hypertensive Black Africans: Insights from the coArtHA Trial
Global Heart · 21.07.2026 · 21 (1) · 57
DOI: 10.5334/gh.1562 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Global Heart, online erschienen am 21.07.2026. Verfasst von Annina S Vischer und 19 weiteren Autor:innen. Beteiligte Einrichtung: Medical Outpatient Department and Hypertension Centre, ESH Hypertension Centre of Excellence, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Black People, Electrocardiography, Hypertension, Hypertrophy, Left Ventricular. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Electrocardiographic (ECG) criteria for detecting left ventricular hypertrophy (LVH) have largely been derived from non-African populations. Their diagnostic performance in Black African adults with untreated hypertension remains uncertain.
Objective
To evaluate the diagnostic performance of established ECG-LVH criteria compared with echocardiographically assessed left ventricular mass index (LVMI) in Black African adults with untreated, uncomplicated hypertension enrolled in the coArtHA trial.
Methods
In this subanalysis, we included 1,125 participants from rural Tanzania and Lesotho who underwent baseline 12-lead ECG and focused transthoracic echocardiography (fTTE). LVH was defined as LVMI > 95 g/m² in women, and >115 g/m² in men. Diagnostic performance of multiple ECG-LVH criteria was assessed using correlation analyses, sensitivity and specificity estimates, receiver-operating characteristic (ROC) analysis, including calculation of the area under the ROC curve (AUROC), and precision-recall curves (PRC).
Results
Echocardiographic LVH was present in 56 (5%) participants. Across continuous ECG indices, Cornell voltage product adjusted by +0.8 mV in women showed the strongest association with LVMI (Spearman’s rho = 0.37, p < 0.001). Among evaluated criteria, Cornell voltage product-based measures demonstrated the most consistent diagnostic performance across evaluated metrics, with an AUROC of approximately 0.76. Using established cut-off values, this criterion yielded a sensitivity of 64% and a specificity of 80%, whereas voltage-only criteria, including Multi-Ethnic Study of Atherosclerosis (MESA)- and Sokolow–Lyon-based indices, showed limited accuracy in this setting. Exploratory analyses of alternative cut-off values demonstrated the expected sensitivity–specificity trade-offs.
Conclusions
In this cohort of hypertensive Black African adults, ECG criteria showed a moderate association with LVMI by echocardiography. Among established ECG criteria, Cornell voltage product-based measures demonstrated the most consistent diagnostic performance. Diagnostic characteristics were strongly influenced by cut-off selection and clinical context, underscoring the need for population-specific evaluation and external validation of ECG criteria for LVH in African settings.
Trial registration
Clinicaltrials.gov NCT04129840. Registered on October 17, 2019 (https://www.clinicaltrials.gov/).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Outpatient Department and Hypertension Centre, ESH Hypertension Centre of Excellence, University Hospital Basel, Basel, Switzerland.
- University of Basel, Basel, Switzerland.
- SolidarMed, Partnerships for Health, Maseru, Lesotho.
- Ifakara Health Institute, Ifakara branch, Ifakara, United Republic of Tanzania.
- Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
- St. Francis Regional Referral Hospital, Ifakara, United Republic of Tanzania.
ORCID-Profile: Annina S Vischer, Valeriya Nemtsova, Blaise Lukau, Martin Rohacek, Johanna Oehri, Herry Mapesi, Fiona Vanobberghen, Andrew Katende, Alain Amstutz, Elizabeth Senkoro, Jamali Siru, Winfrid Gingo, Niklaus Daniel Labhardt, Maja Weisser, Thilo Burkard
Zitieren
APA
Vischer, A. S., Nemtsova, V., Lukau, B., Rohacek, M., Macko, J., Oehri, J., Mapesi, H., Vanobberghen, F., Katende, A., Gupta, R., Wilson, H. I., Amstutz, A., Senkoro, E., Byakuzana, T., Mbunda, G., Siru, J., Gingo, W., Labhardt, N. D., Weisser, M., & Burkard, T. (2026). ECG Criteria for Left Ventricular Hypertrophy in Hypertensive Black Africans: Insights from the coArtHA Trial. Global Heart, 21(1), 57. https://doi.org/10.5334/gh.1562
Vancouver
Vischer AS, Nemtsova V, Lukau B, Rohacek M, Macko J, Oehri J, et al. ECG Criteria for Left Ventricular Hypertrophy in Hypertensive Black Africans: Insights from the coArtHA Trial. Global Heart. 2026;21(1):57. doi:10.5334/gh.1562
BibTeX
@article{Vischer2026,
author = {Vischer, Annina S and Nemtsova, Valeriya and Lukau, Blaise and Rohacek, Martin and Macko, Jonathan and Oehri, Johanna and Mapesi, Herry and Vanobberghen, Fiona and Katende, Andrew and Gupta, Ravi and Wilson, Herieth Ismael and Amstutz, Alain and Senkoro, Elizabeth and Byakuzana, Theonestina and Mbunda, Geofrey and Siru, Jamali and Gingo, Winfrid and Labhardt, Niklaus Daniel and Weisser, Maja and Burkard, Thilo},
title = {ECG Criteria for Left Ventricular Hypertrophy in Hypertensive Black Africans: Insights from the coArtHA Trial},
journal = {Global Heart},
year = {2026},
volume = {21},
number = {1},
pages = {57},
doi = {10.5334/gh.1562}
}
EUVIMED